يعرض 1 - 10 نتائج من 36 نتيجة بحث عن '"Katja Seipel"', وقت الاستعلام: 0.84s تنقيح النتائج
  1. 1

    المصدر: Cancers; Volume 14; Issue 10; Pages: 2516
    Rentsch, Vera; Seipel, Katja; Banz, Yara; Wiedemann, Gertrud; Porret, Naomi; Bacher, Ulrike; Pabst, Thomas (2022). Glofitamab Treatment in Relapsed or Refractory DLBCL after CAR T-Cell Therapy. Cancers, 14(10) MDPI AG 10.3390/cancers14102516 <http://dx.doi.org/10.3390/cancers14102516Test>

    وصف الملف: application/pdf

  2. 2
  3. 3
  4. 4
  5. 5

    المصدر: HemaSphere
    Schnell, Bianca R.; Seipel, Katja; Bacher, Ulrike; Jeker, Barbara; Mueller, Beatrice U.; Banz, Yara; Novak, Urban; Pabst, Thomas (2019). Rebound Thrombocytosis after Induction Chemotherapy is a Strong Biomarker for Favorable Outcome in AML Patients. HemaSphere, 3(2), e180. Wolters Kluwer Health 10.1097/HS9.0000000000000180 <http://dx.doi.org/10.1097/HS9.0000000000000180Test>
    HemaSphere, Vol 3, Iss 2 (2019)

    وصف الملف: application/pdf

  6. 6

    المصدر: Cancers, Vol 11, Iss 11, p 1779 (2019)
    Cancers
    Volume 11
    Issue 11
    Seipel, Katja; Schmitter, Karin; Bacher, Ulrike; Pabst Müller, Thomas Niklaus (2019). Rationale for a Combination Therapy Consisting of MCL1-and MEK-Inhibitors in Acute Myeloid Leukemia. Cancers, 11(11) MDPI AG 10.3390/cancers11111779 <http://dx.doi.org/10.3390/cancers11111779Test>

    وصف الملف: application/pdf

  7. 7
  8. 8

    المصدر: Cancers, Vol 10, Iss 6, p 170 (2018)
    Cancers
    Volume 10
    Issue 6
    Seipel, Katja; Marques, Miguel A T; Sidler, Corinne; Mueller, Beatrice U; Pabst Müller, Thomas Niklaus (2018). The Cellular p53 Inhibitor MDM2 and the Growth Factor Receptor FLT3 as Biomarkers for Treatment Responses to the MDM2-Inhibitor Idasanutlin and the MEK1 Inhibitor Cobimetinib in Acute Myeloid Leukemia. Cancers, 10(6) MDPI AG 10.3390/cancers10060170 <http://dx.doi.org/10.3390/cancers10060170Test>

    وصف الملف: application/pdf

  9. 9
  10. 10